Key points from article :
Interview with Dr. Alex Zhavoronkov, CEO of Insilico Medicine
Company awarded the ‘Most Promising Company’ title at Personalised Medicine World Conference in 2015.
In 5 years we want to build a comprehensive system to model and monitor the human health status and rapidly correct any deviations.
Main breakthroughs expected in the area of multi-modal biomarkers of aging.
“Applying AI to aging is the only way to bring it under the comprehensive medical control.”
